FDA Inspection 771601 — Octapharma plasma Inc.

Octapharma plasma Inc. — FEI 1073111

The FDA completed an inspection of Octapharma plasma Inc. on February 8, 2012 in Columbia, SC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 8, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Columbia, SC (United States)

Citations

IDCFRDescription
15521 CFR 606.160(b)Required records